atai life sciences: psychedelics, mental health, & drug development w/ founder christian angermayer
Published 2 months ago • 752 plays • Length 46:28Download video MP4
Download video MP3
Similar videos
-
3:59
atai life sciences founder on using psychedelics to treat mental illness
-
26:21
florian brand (atai life sciences): psychedelics – the new psychiatric frontier | slush 2021
-
8:54
psychedelics might change mental healthcare. will investors follow?
-
28:57
how legal psychedelics can cure mental health - trade to black #10
-
1:07:25
christian angermayer: investing in the therapeutic potential for psychedelics
-
11:56
atai life sciences 'bringing innovation to mental healthcare and treatment addiction'
-
25:46
psychedelic leader reports earnings | ceo florian brand - atai life sciences
-
29:11
what's the future of psychedelic medicine beyond 2020?
-
26:56
psychedelics: effects on the human brain and physiology | simeon keremedchiev | tedxvarna
-
2:56:44
psychedelic medicine: from tradition to science
-
28:15
may 2020: psychedelics and psychedelic-assisted psychotherapy
-
24:42
founder stories: christian angermayer, founder of atai life sciences
-
37:02
dr. srinivas rao - cso, atai life sciences - transforming the treatment of mental health disorders
-
7:07
atai life sciences outlines key milestones in psychedelic therapy for depression in 2023 and 2024
-
33:00
florian brand talks of innovation in mental healthcare to tackle depression, anxiety and addiction
-
33:29
atai founder reveals 14 reasons to remain optimistic - tdr exclusive
-
20:20
atai life sciences: earnings report breakdown and pipeline highlights | $atai
-
34:24
is now a good time to invest in atai?
-
4:04
psychedelics and psychiatry
-
50:27
episode 9: analyzing the atai life sciences ipo
-
4:51
are psychedelics the future for therapy?
-
10:51
atai life sciences stock analysis: should i buy or sell this psychedelic stock? $atai stock analysis